M1 signature mediators in atheroma-derived single cell secretome of symptomatic plaques

Sabine Steffens

doi:10.1160/TH16-03-0245

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2016; 115(05): 871
DOI: 10.1160/TH16-03-0245

T&H Insights

Schattauer GmbH

M1 signature mediators in atheroma-derived single cell secretome of symptomatic plaques

Sabine Steffens

¹Institute for Cardiovascular Prevention and German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Ludwig-Maximilians-University (LMU), Munich, Germany

References
1 Yla-Herttuala S, Bentzon JF, Daemen M. et al. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology. Thromb Haemost 2011; 106: 1-19.
2 Hellings WE, Peeters W, Moll FL. et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 2010; 121: 1941-1950.
3 Tabas I, Bornfeldt KE. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. Circulation Res 2016; 118: 653-667.
4 Shalhoub J, Viiri LE, Cross AJ. et al. Multi-analyte profiling in human carotid atherosclerosis uncovers pro-inflammatory macrophage programming in plaques. Thromb Haemost 2016; 116: 1064-1072.
5 Hoefer IE, Steffens S, Ala-Korpela M. et al. Novel methodologies for biomarker discovery in atherosclerosis. Eur Heart J 2015; 36: 2635-2642.